Cargando…
Stent thrombosis and restenosis: what have we learned and where are we going? The Andreas Grüntzig Lecture ESC 2014
Modern-day stenting procedures leverage advances in pharmacotherapy and device innovation. Patients treated with contemporary antiplatelet agents, peri-procedural antithrombin therapy and new-generation drug-eluting stents (DES) have excellent outcomes over the short to medium term. Indeed, coupled...
Autores principales: | Byrne, Robert A., Joner, Michael, Kastrati, Adnan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4677274/ https://www.ncbi.nlm.nih.gov/pubmed/26417060 http://dx.doi.org/10.1093/eurheartj/ehv511 |
Ejemplares similares
-
Balloon Angioplasty – The Legacy of Andreas Grüntzig, M.D. (1939–1985)
por: Barton, Matthias, et al.
Publicado: (2014) -
Perspectives on the 2014 ESC/EACTS Guidelines on Myocardial Revascularization: Fifty Years of Revascularization: Where Are We and Where Are We Heading?
por: Costa, Francesco, et al.
Publicado: (2015) -
Modern Stents: Where Are We Going?
por: Kobo, Ofer, et al.
Publicado: (2020) -
Spontaneous Resolution of Portal Vein Thrombosis in Cirrhosis: Where do we Stand, and Where will we Go?
por: Qi, Xingshun, et al.
Publicado: (2014) -
The Clusmy Child: Where Are We and Where Are We Going?
por: Hadders-Algra, Mijna, et al.
Publicado: (2003)